Subscribe
Alert
Please keep in mind that merely contacting Nelson Mullins Riley & Scarborough LLP will not establish an attorney-client relationship. Nelson Mullins cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. Accordingly, please do not send Nelson Mullins any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and authorized in the form of an engagement letter from Nelson Mullins. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature. Clicking "Submit" acknowledges that you understand and agree with this notice.
Michael D. Bryan
Partner
Liberty Center
151 Meeting Street
Suite 600
Charleston, SC 29401
151 Meeting Street
Suite 600
Charleston, SC 29401
Atlantic Station
201 17th Street NW
Suite 1700
Atlanta, GA 30363
201 17th Street NW
Suite 1700
Atlanta, GA 30363
mike.bryan@nelsonmullins.com
Mike focuses his practice on a wide variety of transactions, including acquisitions, divestitures, joint ventures, licensing, and debt and equity offerings. He advises clients in the agricultural and industrial biotechnology, manufacturing, chemical, and healthcare industries. He also regularly advises clients on matters related to corporate governance, securities law compliance and reporting requirements, stock exchange rules,...
Mike focuses his practice on a wide variety of transactions, including acquisitions, divestitures, joint ventures, licensing, and debt and equity offerings. He advises clients in the agricultural and industrial biotechnology, manufacturing, chemical, and healthcare industries. He also regularly advises clients on matters related to corporate governance, securities law compliance and reporting requirements, stock exchange rules, executive compensation, boards of directors, and compliance.
executive compensation, boards of directors, and compliance.
Experience
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Represented an agricultural biotechnology company in its $760 million initial public offering
- Represented a private company that is a leading developer of biotechnology–improved trees in its $70 million acquisition of three nursery and tree development businesses in the United States, New Zealand, and Australia
- Represented a public agricultural biotechnology company in its $1.4 billion acquisition of a global seed business with operations in 29 countries
- Represented a public agricultural biotechnology company in the spinoff of its chemical business with a market capitalization of $3 billion
- Represented a public agricultural biotechnology company in its $435 million acquisition of a biotechnology and pharmaceutical research campus from a public pharmaceutical company
- Represented a private equity investor in its $604 million acquisition of a life insurance company
- Represented a public company in connection with a Government Accounting Office investigation related to product pricing in the United States and Argentina
- Represented a nonprofit hospital system in connection with multiple bond financings totaling more than $400 million
- Represented a public company in its $2.5 billion leveraged recapitalization involving a $1.1 billion note offering and a self–tender offer
- Represented a public company in its $140 million divestiture of its retail sales and finance businesses
- Represented a public company in its $60 million acquisition of an industrial manufacturing business
- Represented Vitamin Shoppe Inc. in its $85 million acquisition of Nutri-Force Nutrition
- Represented Ceres Inc. in its acquisition by Land O’Lakes Inc.
- Represented a value-based healthcare organization in its acquisition by a public value-based healthcare company
- Represented an industrial hemp company in its collaboration with a Swiss genomics-based plant breeding company
- Represented a public company in its $157 million divestiture of an industrial division
- Represented a German public company in its $40 million acquisition of a warehouse systems business from a French company
- Represented a German public company in its minority investment in a Chinese manufacturing company
Previous Professional Experience
- Partner, corporate, securities, and mergers and acquisitions practice at an international law firm (2013–2019)
- Partner, corporate, securities and mergers and acquisitions practice, Nelson Mullins Riley & Scarborough LLP (2003–2013)
- Associate General Counsel, Monsanto Company (1997–2003)
Education
- University of Kentucky College of Law, JD (1983)
- University of Kentucky, BBA, Finance (1980)
Admissions
- South Carolina
- Georgia
- Texas
Practice Areas
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
- Represented an agricultural biotechnology company in its $760 million initial public offering
- Represented a private company that is a leading developer of biotechnology–improved trees in its $70 million acquisition of three nursery and tree development businesses in the United States, New Zealand, and Australia
- Represented a public agricultural biotechnology company in its $1.4 billion acquisition of a global seed business with operations in 29 countries
- Represented a public agricultural biotechnology company in the spinoff of its chemical business with a market capitalization of $3 billion
- Represented a public agricultural biotechnology company in its $435 million acquisition of a biotechnology and pharmaceutical research campus from a public pharmaceutical company
- Represented a private equity investor in its $604 million acquisition of a life insurance company
- Represented a public company in connection with a Government Accounting Office investigation related to product pricing in the United States and Argentina
- Represented a nonprofit hospital system in connection with multiple bond financings totaling more than $400 million
- Represented a public company in its $2.5 billion leveraged recapitalization involving a $1.1 billion note offering and a self–tender offer
- Represented a public company in its $140 million divestiture of its retail sales and finance businesses
- Represented a public company in its $60 million acquisition of an industrial manufacturing business
- Represented Vitamin Shoppe Inc. in its $85 million acquisition of Nutri-Force Nutrition
- Represented Ceres Inc. in its acquisition by Land O’Lakes Inc.
- Represented a value-based healthcare organization in its acquisition by a public value-based healthcare company
- Represented an industrial hemp company in its collaboration with a Swiss genomics-based plant breeding company
- Represented a public company in its $157 million divestiture of an industrial division
- Represented a German public company in its $40 million acquisition of a warehouse systems business from a French company
- Represented a German public company in its minority investment in a Chinese manufacturing company
Previous Professional Experience
- Partner, corporate, securities, and mergers and acquisitions practice at an international law firm (2013–2019)
- Partner, corporate, securities and mergers and acquisitions practice, Nelson Mullins Riley & Scarborough LLP (2003–2013)
- Associate General Counsel, Monsanto Company (1997–2003)
Media
Professional Activities
- American Bar Association
- Society for Corporate Governance, Advisory Committee, Southeastern Chapter
- Charleston County Bar Association
- Council for Entrepreneurial Development
- German American Chamber of Commerce of the Southern United States
- Junior Achievement of Greater South Carolina, Coastal Advisory Board
Mike focuses his practice on a wide variety of transactions, including acquisitions, divestitures, joint ventures, licensing, and debt and equity offerings. He advises clients in the agricultural and industrial biotechnology, manufacturing, chemical, and healthcare industries. He also regularly advises clients on matters related to corporate governance, securities law compliance and reporting requirements, stock exchange rules,... executive compensation, boards of directors, and compliance.
Experience
The following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.- Represented an agricultural biotechnology company in its $760 million initial public offering
- Represented a private company that is a leading developer of biotechnology–improved trees in its $70 million acquisition of three nursery and tree development businesses in the United States, New Zealand, and Australia
- Represented a public agricultural biotechnology company in its $1.4 billion acquisition of a global seed business with operations in 29 countries
- Represented a public agricultural biotechnology company in the spinoff of its chemical business with a market capitalization of $3 billion
- Represented a public agricultural biotechnology company in its $435 million acquisition of a biotechnology and pharmaceutical research campus from a public pharmaceutical company
- Represented a private equity investor in its $604 million acquisition of a life insurance company
- Represented a public company in connection with a Government Accounting Office investigation related to product pricing in the United States and Argentina
- Represented a nonprofit hospital system in connection with multiple bond financings totaling more than $400 million
- Represented a public company in its $2.5 billion leveraged recapitalization involving a $1.1 billion note offering and a self–tender offer
- Represented a public company in its $140 million divestiture of its retail sales and finance businesses
- Represented a public company in its $60 million acquisition of an industrial manufacturing business
- Represented Vitamin Shoppe Inc. in its $85 million acquisition of Nutri-Force Nutrition
- Represented Ceres Inc. in its acquisition by Land O’Lakes Inc.
- Represented a value-based healthcare organization in its acquisition by a public value-based healthcare company
- Represented an industrial hemp company in its collaboration with a Swiss genomics-based plant breeding company
- Represented a public company in its $157 million divestiture of an industrial division
- Represented a German public company in its $40 million acquisition of a warehouse systems business from a French company
- Represented a German public company in its minority investment in a Chinese manufacturing company
Previous Professional Experience
- Partner, corporate, securities, and mergers and acquisitions practice at an international law firm (2013–2019)
- Partner, corporate, securities and mergers and acquisitions practice, Nelson Mullins Riley & Scarborough LLP (2003–2013)
- Associate General Counsel, Monsanto Company (1997–2003)
Education
- University of Kentucky College of Law, JD (1983)
- University of Kentucky, BBA, Finance (1980)
Admissions
- South Carolina
- Georgia
- Texas
Practice Areas
Industries
- American Bar Association
- Society for Corporate Governance, Advisory Committee, Southeastern Chapter
- Charleston County Bar Association
- Council for Entrepreneurial Development
- German American Chamber of Commerce of the Southern United States
- Junior Achievement of Greater South Carolina, Coastal Advisory Board
Highlights from the Firm’s Insights
“Prime Equity” and the NIL Era: Shedeur Sanders’ Contract Ushers...
September 3, 2025
From the Ballpark to the Courtroom: “Babe Ruth” Charged in...
August 26, 2025
Old North State Report – September 26, 2025
September 29, 2025
FCC Download: Monthly Updates - September 2025
September 19, 2025